Brief Advice: Clinical Trials

4 trials of Brief Advice, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Withdrawn 1
Phase 12Completed 1, Withdrawn 1

Follow Brief Advice: new trials by email Literature Review of Brief Advice trials Research Report on Brief Advice

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
Motivation Enhancement Therapy, Modified Behavioral Self-Control Therapy, Naltrexone - Alcohol-Related Disorders, Alcohol Drinking
Phase 1 / Phase 2CompletedNorthwell Health272017-01-012023-10-30
cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use
Computer Screening, Brief Intervention, Referral toTreatment - Tobacco Abuse, Alcohol Abuse
Phase 1 / Phase 2WithdrawnBoston Children's Hospital2011-09-012016-10-07
Therapeutic Substance Abuse Treatment in Pregnancy - 1
MI-CBT, Brief Advice - Alcohol Abuse, Cocaine Abuse
Phase 2CompletedYale University1682004-09-012020-04-15
Healthy Living as You Age
Brief advice - Alcohol Related Disorders, Alcohol Drug Interactions
Phase 2CompletedNational Institute on Alcohol Abuse and Alcoholism (NIAAA)6312003-08-012009-07-13

Conditions studied

Alcoholism (3)  ·  Alcohol-Related Disorders (2)  ·  Alcohol Drinking (1)  ·  Cocaine-Related Disorders (1)  ·  Marijuana Abuse (1)  ·  Substance-Related Disorders (1)  ·  Tobacco Use (1)  ·  Tobacco Use Disorder (1)

Sponsors

Boston Children's Hospital (1)  ·  National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)  ·  Northwell Health (1)  ·  Yale University (1)

Countries

United States (4)

Top investigators

Alison A. Moore, MD, MPH (1)  ·  John R. Knight, MD (1)  ·  Kimberly A Yonkers, M.D. (1)

Results publications

PMID 22795046, PMID 24447885, PMID 28270105, PMID 33605440

NIH funding

R01DA019135 (1), R34AA024589 (1)